Koshinski Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
3,447
+947
+38% +$455K 0.09% 199
2026
Q1
$1.23M Sell
2,500
-351
-12% -$190K 0.08% 244
2025
Q4
$1.65M Sell
2,851
-331
-10% -$187K 0.11% 178
2025
Q3
$1.54M Sell
3,182
-54
-2% -$25.1K 0.1% 189
2025
Q2
$1.31M Buy
3,236
+96
+3% +$40.1K 0.1% 205
2025
Q1
$1.56M Buy
3,140
+440
+16% +$238K 0.13% 163
2024
Q4
$1.4B Buy
2,700
+54
+2% +$29.7K 0.12% 166
2024
Q3
$1.64M Sell
2,646
-1,631
-38% -$965K 0.14% 144
2024
Q2
$2.27M Buy
4,277
+62
+1% +$35.5K 0.21% 102
2024
Q1
$2.45M Buy
4,215
+1,108
+36% +$622K 0.25% 87
2023
Q4
$1.65M Sell
3,107
-2,207
-42% -$1.07M 0.25% 108
2023
Q3
$2.69M Sell
5,314
-29
-0.5% -$15.5K 0.31% 72
2023
Q2
$2.79M Sell
5,343
-2,121
-28% -$1.14M 0.3% 76
2023
Q1
$4.3M Buy
7,464
+230
+3% +$130K 0.42% 53
2022
Q4
$3.98M Buy
7,234
+86
+1% +$45.6K 0.39% 58
2022
Q3
$3.63M Buy
7,148
+251
+4% +$140K 0.43% 55
2022
Q2
$3.75M Sell
6,897
-31
-0.4% -$17.1K 0.37% 64
2022
Q1
$4.09M Buy
6,928
+58
+0.8% +$33.3K 0.34% 68
2021
Q4
$4.58M Buy
6,870
+54
+0.8% +$33.7K 0.37% 54
2021
Q3
$3.89M Buy
6,816
+2,067
+44% +$1.13M 0.34% 62
2021
Q2
$2.4M Sell
4,749
-2,041
-30% -$963K 0.3% 83
2021
Q1
$3.1M Buy
6,790
+39
+0.6% +$18.6K 0.33% 77
2020
Q4
$3.15M Buy
6,751
+1,277
+23% +$599K 0.4% 58
2020
Q3
$2.56K Buy
5,474
+175
+3% +$72.3K 0.34% 70
2020
Q2
$1.92M Buy
5,299
+28
+0.5% +$9.38K 0.31% 83
2020
Q1
$1.5M Sell
5,271
-14
-0.3% -$4.42K 0.31% 84
2019
Q4
$1.72M Buy
5,285
+508
+11% +$154K 0.3% 95
2019
Q3
$1.39M Sell
4,777
-1,349
-22% -$386K 0.97% 31
2019
Q2
$1.8M Sell
6,126
-233
-4% -$64.2K 0.73% 32
2019
Q1
$1.74K Hold
6,359
0.47% 52
2018
Q4
$1.42M Sell
6,359
-932
-13% -$219K 0.35% 81
2018
Q3
$1.78M Buy
7,291
+3,952
+118% +$909K 0.25% 115
2018
Q2
$692K Hold
3,339
0.21% 153
2018
Q1
$689K Sell
3,339
-773
-19% -$162K 0.21% 159
2017
Q4
$781K Buy
4,112
+13
+0.3% +$2.49K 0.2% 179
2017
Q3
$776K Buy
4,099
+22
+0.5% +$3.98K 0.25% 129
2017
Q2
$711K Buy
4,077
+1,127
+38% +$189K 0.26% 126
2017
Q1
$453K Sell
2,950
-43
-1% -$6.57K 0.18% 173
2016
Q4
$422K Sell
2,993
-106
-3% -$15.6K 0.21% 155
2016
Q3
$493K Buy
3,099
+113
+4% +$17.4K 0.25% 136
2016
Q2
$441K Buy
2,986
+230
+8% +$33.9K 0.24% 138
2016
Q1
$390K Buy
+2,756
New +$369K 0.25% 131

Other funds holding TMO

Koshinski Asset Management's TMO Position: Q2 2026 in Review

Koshinski Asset Management increased its Thermo Fisher Scientific (TMO) stake by 38% in Q2 2026, buying an estimated $455K and bringing the position to 3,447 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #199.

Koshinski Asset Management first reported a position in TMO in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.4B in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Koshinski Asset Management held 3,447 shares of Thermo Fisher Scientific worth $1.73M as of Q2 2026.
  • Koshinski Asset Management bought 947 Thermo Fisher Scientific shares in Q2 2026, an estimated $455K.
  • Thermo Fisher Scientific made up 0.09% of Koshinski Asset Management's portfolio in Q2 2026, its #199 holding.
  • Koshinski Asset Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 42 quarters since.
  • Koshinski Asset Management's Thermo Fisher Scientific position peaked at $1.4B in Q4 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.